BSEEverest Organics Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 28 May, 2025 · 22:33 IST

Outcome of the Board Meeting is enclosed

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.9%Reaction day
₹435.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+0.6% vs market
Pharmaceuticals peers, median of 147sector+0.5%+0.4% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.9+0.4+0.6+0.5+0.4
Next day
-0.2+0.7-0.9-0.2-0.0
2d
+1.0+0.7+0.2-0.3+1.3
3d
-1.8+0.5-2.3-0.4-1.4
4d
-3.9+1.0-4.9-0.1-3.8
5d
-4.1+1.5-5.6-0.1-4.1
1w
-3.4+2.8-6.3+0.5-3.9
15d
-24.3-0.7-23.6-2.8-21.5
1m
-14.7+3.7-18.4+0.2-15.0
2m
-23.9+3.0-26.9+1.4-25.3
3m
-9.3-1.4-7.8-4.0-5.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Everest Organics met over two days (May 27-28, 2025) and approved three auditor-related decisions. It appointed M/s. RPR & Associates, Practicing Company Secretaries based in Hyderabad, as the new Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30, subject to shareholder approval at the upcoming 32nd AGM. The Board also re-appointed M/s. Harikrishna & Associates as Internal Auditors for FY 2025-26 and M/s. P.K.R. & Associates LLP as Cost Auditors for FY 2025-26, the latter also needing shareholder approval for remuneration. No financial results, business updates, or operational matters were discussed in this filing.

Likely market impact

This is a routine corporate governance announcement with no direct impact on shareholders' wealth or stock price. Investors should note that the shareholder approvals sought at the AGM are standard procedural items.